Sage Therapeutics, Inc.
Neuroactive steroid formulations and methods of treating CNS disorders
Last updated:
Abstract:
Formulations of comprising a neuroactive steroid, e.g., allopregnanolone; and optionally a cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., CAPTISOL.RTM.; and methods of use in treating CNS disorders.
Status:
Grant
Type:
Utility
Filling date:
26 Apr 2019
Issue date:
30 Aug 2022